Although these studies clearly demonstrate that a complete abolishment of BACE1 activities or Aβ production is not required for functional improvements, it has not been examined whether the beneficial effects of partial BACE1 suppression may remain unchanged during highly advanced stages of AD. This evidence concerns the gene BACE1 and Alzheimer disease.